Diagnostics involves investigating and discovering certain diseases, conditions and injuries by closely studying various symptoms and indications displayed by patients. In broad terms, today’s Diagnostics Industry breaks down into the following categories, namely in-vitro diagnostics (IVD) (examination of diverse tissue samples in a laboratory) and in-vivo diagnostics (observation and testing of tissue and any organ’s functioning by exploiting the techniques like medical (diagnostic) imaging and monitoring).
A nearly EUR 37.5 billion sector, in-vitro diagnostics promises enormous growth potential, with governments increasingly redefining soaring healthcare spending and starting to pour investments into the high tech diagnostics business. The latter continues to be superintended by a mere scattering of behemoths. Major forces fuelling the industry development include, among others, innovative approaches regarding equipment and clinical trial activities.
This Catalogue presents an invaluable collection of research reports examining the Diagnostics and Diseases Market worldwide, by various regions and selected countries. The research reports feature market sizing analyses and growth rate reviews, discussions of factors diving or deterring the growth of the Diagnostics and Diseases Industry, information on market dynamics and share, etc. The profiles of large-to-micro caps, and the Diagnostics and Diseases Market forecasts are provided in the research reports too.
Publications found:
43,378
Sort by:
South Korea In-Vitro Diagnostics Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Government Initiatives, Key Company Profiles, Revenue, Recent Developments - Forecast to 2030
US$ 1,890.00
South Korea in-vitro diagnostics market is projected to reach US$ 5,014 Million by 2030, from US$ 3,466 Million in 2023. In-vitro diagnostics refers to the diagnosis of disease or other condition of t...
February 2024
297 pages
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]) Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospital, Imaging Center, Pharmaceutical) - Forecast to 2031
US$ 4,175.00
Europe Cancer Diagnostics Market by Product (IVD [Microarray, Immunoassay, PCR, Sequencing], Imaging [CT, MRI, Mammography, Ultrasound]), Cancer Type (Breast, Lung, Colon, Prostate), End User (Hospita...
February 2024
209 pages
Multi-Cancer Diagnostic Tests: Global Market Outlook
US$ 3,500.00
Report : The current report provides detailed exposure to the MCD test market and highlights the current and future market potential of the tests along with a detailed analysis of the drivers and chal...
February 2024
50 pages
Prevention and Treatment of Prostate Cancer: Technologies and Global Markets
US$ 5,500.00
The global market for prostate cancer products reached nearly $47.2 billion in 2016 and should reach nearly $65.1 billion in ... should reach $27.4 billion in 2021, with a CAGR of 7.2 %. Surgical and radiation therapy as a segment reached nearly $14.4 billion in 2016 and should reach $20.8 billion ...
January 2024
157 pages
2024 Dell Performance, Capabilities, Goals and Strategies
US$ 950.00
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...
January 2024
2024 LG Performance, Capabilities, Goals and Strategies
US$ 950.00
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...
January 2024
2024 P&G Performance, Capabilities, Goals and Strategies
US$ 950.00
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide. The report provides significant competitor informat...
January 2024
